Author:
Huang Chun-Teng,Liu Chia-Jen,Ko Po-Shen,Liu Han-Tsung,Yu Yuan-Bin,Hsiao Liang-Tsai,Gau Jyh-Pyng,Tzeng Cheng-Hwai,Chiou Tzeon-Jye,Liu Jin-Hwang,Yang Muh-Hwa,Huang Ling-Ju,Liu Chun-Yu
Funder
Taipei Veterans General Hospital
Taipei City Hospital
Taiwan Clinical Oncology Research Foundation
Chong Hin Loon Memorial Cancer and the Biotherapy Research Center of National Yang-Ming University
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Rayner HC, Haynes AP, Thompson JR, Russell N, Fletcher J. Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988. Q J Med. 1991;79:517–25.
2. Murakami H, Hayashi K, Hatsumi N, Saitoh T, Yokohama A, Matsushima T, et al. Risk factors for early death in patients undergoing treatment for multiple myeloma. Ann Hematol. 2001;80:452–5.
3. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21–33.
4. Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002—Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2005;23:9219–26.
5. Jacobson DR, Zolla-Pazner S. Immunosuppression and infection in multiple myeloma. Semin Oncol. 1986;13:282–90.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献